All lobbying filings
ULTRAGENYX PHARMACEUTICAL INC.
Lobbying for ULTRAGENYX PHARMACEUTICAL INC. · Pharmaceuticals
Filing
1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$330,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
3
Issues related to drug development, access and reimbursement for rare and ultra rare diseases.
Issues related to drug development, access and reimbursement for rare and ultra rare diseases.
Issues related to drug development, access and reimbursement for rare and ultra rare diseases.